Skip to main content
Kelly Fitzpatrick, MD, Hematology, Neptune, NJ

Kelly West Fitzpatrick MD (She/Her)

Hematologic Oncology


Hematologist/Oncologist, Regional Cancer Care Associates, LLC and JTCC; HOPE Tower: Hackensack Meridian Health Jersey Shore University Medical Center

Join to View Full Profile
  • 19 Davis AvenueHope Tower - 2nd FloorNeptune, NJ 07753

  • Phone+1 732-897-3530

  • Fax+1 732-776-4109

Dr. Fitzpatrick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Kelly Fitzpatrick is a hematologist-oncologist with Regional Cancer Care Associates in NJ, primarily as part of the HOPE tower Leukemia and BMT team at Hackensack Meridian Jersey Shore University Medical Center but also affiliated with the John Theurer Cancer Center in Hackensack since Nov 2021. Previously, she worked as an academic hematologist at MedStar Washington Hospital Center in DC.

Education & Training

  • MedStar Health Georgetown University
    MedStar Health Georgetown UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
  • MedStar Health Georgetown University/Georgetown Hospital
    MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2006 - 2009
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 2006

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2006 - 2026
  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • MD State Medical License
    MD State Medical License 2012 - 2022
  • VA State Medical License
    VA State Medical License 2006 - 2022
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2012, 2014

Publications & Presentations

PubMed

Journal Articles

  • 90Y-Epratuzumab, a Humanized Yttrium-Radiolabeled Anti-CD22mAb for the Potential Treatment of Non-Hodgkin's Lymphoma.  
    KW Fitzpatrick, BD Cheson, Thomas Reuters Drug Profiles, 2/20/2012

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: